{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:23:56Z","timestamp":1790821436095,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00259-019-04633-9","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T09:04:46Z","timestamp":1576227886000},"page":"1510-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-0106","authenticated-orcid":false,"given":"Charlotte","family":"Lussey-Lepoutre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Drossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paule","family":"Benit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Rustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Groussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tchao","family":"Meatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Tavitian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"issue":"4","key":"4633_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"A Buffet","year":"2019","unstructured":"Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libe R, et al. Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma. J Clin Endocrinol Metab. 2019;104(4):1109\u201318. https:\/\/doi.org\/10.1210\/jc.2018-02411.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4633_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101\u201311. https:\/\/doi.org\/10.1038\/nrendo.2014.188.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"4633_CR3","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92(10):3822\u20138. https:\/\/doi.org\/10.1210\/jc.2007-0709.","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"4633_CR4","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, et al. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 2003;63(17):5615\u201321.","journal-title":"Cancer Res"},{"issue":"9","key":"4633_CR5","doi-asserted-by":"publisher","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","volume":"4","author":"J Favier","year":"2009","unstructured":"Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, Benit P, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One. 2009;4(9):e7094. https:\/\/doi.org\/10.1371\/journal.pone.0007094.","journal-title":"PLoS One"},{"issue":"6","key":"4633_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouze","year":"2013","unstructured":"Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 2013;23(6):739\u201352. https:\/\/doi.org\/10.1016\/j.ccr.2013.04.018.","journal-title":"Cancer Cell"},{"issue":"10","key":"4633_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/ijc.29080","volume":"135","author":"A Morin","year":"2014","unstructured":"Morin A, Letouze E, Gimenez-Roqueplo AP, Favier J. Oncometabolites-driven tumorigenesis: from genetics to targeted therapy. Int J Cancer. 2014;135(10):2237\u201348. https:\/\/doi.org\/10.1002\/ijc.29080.","journal-title":"Int J Cancer"},{"issue":"1","key":"4633_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005;7(1):77\u201385. https:\/\/doi.org\/10.1016\/j.ccr.2004.11.022.","journal-title":"Cancer Cell"},{"issue":"15","key":"4633_CR9","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005;14(15):2231\u20139. https:\/\/doi.org\/10.1093\/hmg\/ddi227.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"4633_CR10","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1210\/jc.2014-2151","volume":"99","author":"S Richter","year":"2014","unstructured":"Richter S, Peitzsch M, Rapizzi E, Lenders JW, Qin N, de Cubas AA, et al. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency. J Clin Endocrinol Metab. 2014;99(10):3903\u201311. https:\/\/doi.org\/10.1210\/jc.2014-2151.","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"4633_CR11","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1158\/1078-0432.CCR-12-3922","volume":"19","author":"JU Rao","year":"2013","unstructured":"Rao JU, Engelke UF, Rodenburg RJ, Wevers RA, Pacak K, Eisenhofer G, et al. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma. Clin Cancer Res. 2013;19(14):3787\u201395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3922.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4633_CR12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","volume":"22","author":"C Lussey-Lepoutre","year":"2016","unstructured":"Lussey-Lepoutre C, Bellucci A, Morin A, Buffet A, Amar L, Janin M, et al. In vivo detection of succinate by magnetic resonance spectroscopy as a Hallmark of SDHx mutations in paraganglioma. Clin Cancer Res. 2016;22(5):1120\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1576.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4633_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4633_CR14","first-page":"73","volume":"192","author":"PF Plouin","year":"2008","unstructured":"Plouin PF, Gimenez-Roqueplo AP, Bertagna X. COMETE, a network for the study and management of hypersecreting adrenal tumors. Bull Acad Natl Med. 2008;192(1):73\u201382 discussion 3-5.","journal-title":"Bull Acad Natl Med"},{"issue":"4","key":"4633_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/mrm.1910310404","volume":"31","author":"PG Webb","year":"1994","unstructured":"Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med. 1994;31(4):365\u201373.","journal-title":"Magn Reson Med"},{"issue":"9","key":"4633_CR16","doi-asserted-by":"publisher","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","volume":"96","author":"E Korpershoek","year":"2011","unstructured":"Korpershoek E, Favier J, Gaal J, Burnichon N, van Gessel B, Oudijk L, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab. 2011;96(9):E1472\u20136. https:\/\/doi.org\/10.1210\/jc.2011-1043.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4633_CR17","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1210\/jc.2014-1870","volume":"100","author":"M Menara","year":"2015","unstructured":"Menara M, Oudijk L, Badoual C, Bertherat J, Lepoutre-Lussey C, Amar L, et al. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma\/paraganglioma. J Clin Endocrinol Metab. 2015;100(2):E287\u201391. https:\/\/doi.org\/10.1210\/jc.2014-1870.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"4633_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH van Nederveen","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10(8):764\u201371. https:\/\/doi.org\/10.1016\/S1470-2045(09)70164-0.","journal-title":"Lancet Oncol"},{"issue":"1\u20132","key":"4633_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cca.2006.05.034","volume":"374","author":"P Benit","year":"2006","unstructured":"Benit P, Goncalves S, Philippe Dassa E, Briere JJ, Martin G, Rustin P. Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin Chim Acta. 2006;374(1\u20132):81\u20136. https:\/\/doi.org\/10.1016\/j.cca.2006.05.034.","journal-title":"Clin Chim Acta."},{"key":"4633_CR20","doi-asserted-by":"publisher","unstructured":"Ben Aim L, Pigny P, Castro-Vega LJ, Buffet A, Amar L, Bertherat J, et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J Med Genet. 2019. https:\/\/doi.org\/10.1136\/jmedgenet-2018-105714.","DOI":"10.1136\/jmedgenet-2018-105714"},{"issue":"4","key":"4633_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.185","volume":"13","author":"RA Toledo","year":"2017","unstructured":"Group NGSiPS, Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, et al. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2017;13(4):233\u201347. https:\/\/doi.org\/10.1038\/nrendo.2016.185.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"4633_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","volume":"52","author":"M Curras-Freixes","year":"2015","unstructured":"Curras-Freixes M, Inglada-Perez L, Mancikova V, Montero-Conde C, Leton R, Comino-Mendez I, et al. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. J Med Genet. 2015;52(10):647\u201356. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103218.","journal-title":"J Med Genet"},{"issue":"3","key":"4633_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1056\/NEJMc070010","volume":"357","author":"FH van Nederveen","year":"2007","unstructured":"van Nederveen FH, Korpershoek E, Lenders JW, de Krijger RR, Dinjens WN. Somatic SDHB mutation in an extraadrenal pheochromocytoma. N Engl J Med. 2007;357(3):306\u20138. https:\/\/doi.org\/10.1056\/NEJMc070010.","journal-title":"N Engl J Med"},{"issue":"7","key":"4633_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","volume":"2","author":"SA Boikos","year":"2016","unstructured":"Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, et al. Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016;2(7):922\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0256.","journal-title":"JAMA Oncol"},{"issue":"8","key":"4633_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/gim.2014.162","volume":"17","author":"L Evenepoel","year":"2015","unstructured":"Evenepoel L, Papathomas TG, Krol N, Korpershoek E, de Krijger RR, Persu A, et al. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med. 2015;17(8):610\u201320. https:\/\/doi.org\/10.1038\/gim.2014.162.","journal-title":"Genet Med"},{"issue":"12","key":"4633_CR26","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/PAS.0000000000000685","volume":"40","author":"EF Mason","year":"2016","unstructured":"Mason EF, Hornick JL. Conventional risk stratification fails to predict progression of succinate dehydrogenase-deficient gastrointestinal stromal tumors: a clinicopathologic study of 76 cases. Am J Surg Pathol. 2016;40(12):1616\u201321. https:\/\/doi.org\/10.1097\/PAS.0000000000000685.","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"4633_CR27","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/djn254","volume":"100","author":"C Ricketts","year":"2008","unstructured":"Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, et al. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst. 2008;100(17):1260\u20132. https:\/\/doi.org\/10.1093\/jnci\/djn254.","journal-title":"J Natl Cancer Inst"},{"key":"4633_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00191","volume":"2","author":"RT Casey","year":"2019","unstructured":"Casey RT, McLean MA, Madhu B, Challis BG, ten Hoopen R, Roberts T, et al. Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumors into clinical utility. JCO Precis Oncol. 2019;2:1\u201312. https:\/\/doi.org\/10.1200\/PO.17.00191.","journal-title":"JCO Precis Oncol"},{"key":"4633_CR29","doi-asserted-by":"publisher","unstructured":"Taieb D, Jha A, Treglia G, Pacak K. Molecular imaging and radionuclide therapy of paraganglioma and pheochromocytoma. Endocr Relat Cancer. 2019. https:\/\/doi.org\/10.1530\/ERC-19-0165.","DOI":"10.1530\/ERC-19-0165"},{"issue":"4","key":"4633_CR30","doi-asserted-by":"publisher","first-page":"M1","DOI":"10.1530\/ERC-15-0246","volume":"22","author":"A Varoquaux","year":"2015","unstructured":"Varoquaux A, le Fur Y, Imperiale A, Reyre A, Montava M, Fakhry N, et al. Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics. Endocr Relat Cancer. 2015;22(4):M1\u20138. https:\/\/doi.org\/10.1530\/ERC-15-0246.","journal-title":"Endocr Relat Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04633-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:16:54Z","timestamp":1607732214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4633"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04633-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the study was obtained from the institutional review board (Comit\u00e9 de Protection des Personnes (CPP) Ile de France II).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent for participation to the study, collection of samples, and subsequent analyses.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}